Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines

被引:217
作者
Mascola, JR
D'Souza, P
Gilbert, P
Hahn, BH
Haigwood, NL
Morris, L
Petropoulos, CJ
Polonis, VR
Sarzotti, M
Montefiori, DC
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] NIAID, Div Aids, NIH, Bethesda, MD 20892 USA
[3] Univ Washington, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98109 USA
[4] Univ Alabama, Dept Med, Birmingham, AL 35294 USA
[5] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
[6] Seattle Biomed Res Inst, Seattle, WA 98109 USA
[7] Natl Inst Communicable Dis, Johannesburg, South Africa
[8] ViroLog Inc, San Francisco, CA 94080 USA
[9] Henry M Jackson Fdn, Rockville, MD 20850 USA
[10] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[11] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
关键词
D O I
10.1128/JVI.79.16.10103-10107.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:10103 / 10107
页数:5
相关论文
共 46 条
[1]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[2]   Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines [J].
Brown, BK ;
Darden, JM ;
Tovanabutra, S ;
Oblander, T ;
Frost, J ;
Sanders-Buell, E ;
de Souza, MS ;
Birx, DL ;
McCutchan, FE ;
Polonis, VR .
JOURNAL OF VIROLOGY, 2005, 79 (10) :6089-6101
[3]   Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission [J].
Derdeyn, CA ;
Decker, JM ;
Bibollet-Ruche, F ;
Mokili, JL ;
Muldoon, M ;
Denham, SA ;
Heil, ML ;
Kasolo, F ;
Musonda, R ;
Hahn, BH ;
Shaw, GM ;
Korber, BT ;
Allen, S ;
Hunter, E .
SCIENCE, 2004, 303 (5666) :2019-2022
[4]   Detection of HIV-1 infection with a green fluorescent protein reporter system [J].
Dorsky, DI ;
Wells, M ;
Harrington, RD .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 13 (04) :308-313
[5]   Anonymity versus commitment: The dangers of education on the internet [J].
Hubert L. Dreyfus .
Ethics and Information Technology, 1999, 1 (1) :15-20
[6]   INTERNATIONAL COLLABORATION COMPARING NEUTRALIZATION AND BINDING ASSAYS FOR MONOCLONAL-ANTIBODIES TO SIMIAN IMMUNODEFICIENCY VIRUS [J].
DSOUZA, MP ;
KENT, KA ;
THIRIART, C ;
COLLIGNON, C ;
MILMAN, G .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) :415-422
[7]   Post-exposure prophylaxis with human monoclonal antibodies prevented SHIV89.6P infection or disease in neonatal macaques [J].
Ferrantelli, F ;
Hofmann-Lehmann, R ;
Rasmussen, RA ;
Wang, T ;
Xu, WD ;
Li, PL ;
Montefiori, DC ;
Cavacini, LA ;
Katinger, H ;
Stiegler, G ;
Anderson, DC ;
McClure, HM ;
Ruprecht, RM .
AIDS, 2003, 17 (03) :301-309
[8]   A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1 [J].
Gao, F ;
Robertson, DL ;
Carruthers, CD ;
Morrison, SG ;
Jian, BX ;
Chen, YL ;
Barré-Sinoussi, F ;
Girard, M ;
Srinivasan, A ;
Abimiku, AG ;
Shaw, GM ;
Sharp, PM ;
Hahn, BH .
JOURNAL OF VIROLOGY, 1998, 72 (07) :5680-5698
[9]   APPLICATION OF A RAPID MICROPLAQUE ASSAY FOR DETERMINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS NEUTRALIZING ANTIBODY-TITERS [J].
HANSON, CV ;
CRAWFORDMIKSZA, L ;
SHEPPARD, HW .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) :2030-2034
[10]   RAPID COMPLEMENTATION ASSAYS MEASURING REPLICATIVE POTENTIAL OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN MUTANTS [J].
HELSETH, E ;
KOWALSKI, M ;
GABUZDA, D ;
OLSHEVSKY, U ;
HASELTINE, W ;
SODROSKI, J .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2416-2420